DeepIntent Selected as Exclusive Healthcare DSP for LG Ads Solutions in the U.S.

Effective immediately, DeepIntent will have exclusive rights as the only DSP healthcare advertisers can use to reach LG Ads Solutions’ 20+ million households nationwide NEW…

Read More
DeepIntent Survey Reveals That Pharmaceutical Advertising Motivates Patients to Research Treatment and Medication Options

NEW YORK, Oct. 27, 2021 — DeepIntent, the leading independent healthcare marketing technology company built purposefully to influence patient health and business outcomes, today released…

Read More
DeepIntent Named a Company of the Year in PM360 2021 Trailblazer Awards

NEW YORK, Oct. 11, 2021 — PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has…

Read More
DeepIntent Launches Audience Marketplace

The release marks the industry’s first and only healthcare-specific data marketplace with ready-to-activate and custom audience segments NEW YORK, Sept. 27, 2021 — DeepIntent, the…

Read More
DeepIntent Awarded Patent for DeepIntent Outcomes™ Technology, Which Optimizes Advertising Campaigns to Increase Script Lift Using Real-World Clinical Data

With patented technology, the DeepIntent® Demand Side Platform is the first and only proven Demand Side Platform to drive up to 35%* higher…

Read More
DeepIntent Expands Healthcare Marketplace By Integrating Major Supply Sources

Partners with Magnite, Xandr, Pubmatic, and TripleLift; offers zero-fee trading for direct deals delivering higher yields and greater operational efficiency NEW YORK, May…

Read More
DeepIntent Launches DeepIntent Outcomes™

Industry’s First Demand-Side Platform Integrated With Real-World Clinical Data to Increase Script Lift, Improving Business Outcomes for Healthcare Marketers Beta leading pharmaceutical brand experienced an…

Read More
DeepIntent Releases Consumer Survey Findings on Impact of Direct-to-Consumer Pharmaceutical Advertising

Demonstrates gap between patients and providers about treatment options NEW YORK, March 25, 2021 – DeepIntent, the leading healthcare marketing technology company built purposefully to…

Read More
DeepIntent CEO Chris Paquette Named to the MM+M 40 Under 40 Class of 2021

Paquette honored amongst the brightest young stars in the evolving and expanding realm of healthcare marketing NEW YORK, February 22, 2021 – DeepIntent, the leading…

Read More